MarketBeat published analyst recommendations for Numinus Wellness, Inc., a healthcare company operating with Health Canada licensed research facilities.
1 report, 1 independent
Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat published analyst recommendations for Numinus Wellness, Inc., a healthcare company operating with Health Canada licensed research facilities.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Health Canada
Department of the Canadian Government that oversees public health
-
MarketBeat
American personal finance blog
Related events
- MarketBeat provided analyst ratings and targets for small-cap healthcare companies Emergent BioSolutions and Entrada Therapeutics.
- MarketBeat provided analyst ratings for Alvotech, a company developing a biosimilar to Humira.
- Rapid Micro Biosystems and Thermo Fisher Scientific are competing in the life sciences/healthcare market, with MarketBeat providing analyst ratings and coverage.
- MarketBeat uses for analyst ratings and competes in the medical device market, involving Teleflex and Vasamed.
- Pro-Dex, Inc. is competing in the medical-surgical products market and was rated and analyzed by MarketBeat on September 1, 2026.